Meet Inspiring Speakers and Experts at our 3000+ Global Conference Series Events with over 1000+ Conferences, 1000+ Symposiums
and 1000+ Workshops on Medical, Pharma, Engineering, Science, Technology and Business.

Explore and learn more about Conference Series : World's leading Event Organizer

Back

Radhey S Srivastava

Radhey S Srivastava

Professor
University of Louisiana at Lafayette
United States Of America

Biography

Radhey S. Srivastava started his academic journey after graduating from India and Japan. He was trained in organometallic chemistry by Prof. Akio Yamamoto, Tokyo Institute of Technology, Japan. He has enjoyed working with several distinguished scientists in the field around the globe. This interaction offered him an excellent opportunity to perform high quality research in inorganic and organometallic chemistry. He research lie in field of homogeneous catalysis and ruthenium anticancer drugs. His group’s current research project includes metal-catalyzed functionalization of C-H bond with special reference to C-N bond formation including asymmetric allylic C-N bond formation. In addition to C-H bond functionalization, we are also engaged in the metal catalyzed deoxydehydration (DODH) of biomass derived polyols to energy and value-added chemicals.

Research Interest

Organometallic: Transition Metal-catalyzed Nitrogenation of Hydrocarbons We discovered that Cu-salts and related complexes catalyze olefins with arylhydroxylamine to produce allyl amines. The reactions occur with remarkable regioselectivity with respect to the alkene and the products are valuable as synthetic intermediates and bioactive targets. Most recently, we discovered asymmetric allylic mination catalyzed by Cu. Medicinal Inorganic Chemistry: Ruthenium-based Metallopharmaceuticals Primarily we are tackling problems related to the synthesis of ruthenium complexes with various heterocyclic amines and their assay on various cancer cell-lines. Another area of development in medicinal inorganic chemistry is the development of ruthenium-based anticancer drugs and strategy to overcome drug resistance. Renewable Biomass Energy: Metal-catalyzed Conversion of Cellulosic Biomass for fuels and value-added chemicals We aim to develop new more robust and economically viable catalytic systems for efficient, selective, economical deoxydehydration reactions of cellulosic biomass. Reactivity studies will test the effectiveness of the new reductants and catalysts, identify and quantify the reaction products, and use this information to develop new processes for valuable products and fuels.